With a majority of the major orthopedic and medical technology companies
having reported now, it's pretty clear that key markets like
orthopedics and surgery are still seeing pretty sluggish performance.
Yet the stocks of companies like Stryker (SYK), Zimmer (ZMH), and Covidien (COV)
have done pretty well over the last year, as investors look for
performance to rebound and return to names that were beaten up a little
too much. Though I still think there's money to be made in Stryker's
stock, the gains are likely to be more gradual from here.
Click below to continue:
Maybe More Than Meets The Eye To Stryker's Numbers
No comments:
Post a Comment